Showing results (1421-1430 of 6,942) with videos related to

Sort By:
Pageof 695
Annals of Translational Medicine|July 18, 2022
Evaluation on clinical performance of the new low-value platelet measurement mode (PLT-8X) of BC-6800PlusYimin Shen, Dongmei Liu, Yong Wang, et al.
Annals of Translational Medicine|July 18, 2022
Exogenous H2S promotes ion channel reconstruction to regulate colonic motility in rats with dinitrobenzene sulfonic acid-induced colitisYing Liu, Ribin Liao, Zhanrong Qiang, et al.
Annals of Translational Medicine|March 14, 2022
A narrative review of long noncoding RNA: insight into neural ischemia/reperfusion mediated by two pathophysiological processes of injury and repairLiang Cai, Bingdong Zhang
Annals of Translational Medicine|March 14, 2022
Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)Xiaobin Shang, Gang Zhao, Fei Liang, et al.
Annals of Translational Medicine|March 14, 2022
Polydatin down-regulates the phosphorylation level of STAT3 and induces pyroptosis in triple-negative breast cancer mice with a high-fat dietMin Liu, Yinan Li, Bingtan Kong, et al.
Annals of Translational Medicine|March 14, 2022
Clinical and molecular impacts of tumor mutational burden in histological and cytological specimens from cancer patientsLin Li, Chuan Chen, Chaojun Liu, et al.
Annals of Translational Medicine|March 14, 2022
Narrative review of the mechanism of natural products and scar formation in wound repairXiaoping Wan, Yangyang Chen, Funeng Geng, et al.
Annals of Translational Medicine|March 14, 2022
MiR-93-5p regulates tumorigenesis and tumor immunity by targeting PD-L1/CCND1 in breast cancerMeng Yang, Ran Xiao, Xinru Wang, et al.
Annals of Translational Medicine|March 14, 2022
mFOLFOXIRI with or without bevacizumab for conversion therapy of RAS/BRAF/PIK3CA mutant unresectable colorectal liver metastases: the FORBES non-randomized phase II trialCailu Shen, Huabin Hu, Yue Cai, et al.
Annals of Translational Medicine|March 14, 2022
The prognostic significance of a novel ferroptosis-related gene model in breast cancerYu-Jie Lu, Yang Gong, Wen-Jing Li, et al.
Pageof 695